tiprankstipranks
Innovent Biologics (IVBXF)
OTHER OTC:IVBXF

Compare Innovent Biologics (IVBXF) vs. Competitors

48 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innovent Biologics
$11.14
$19.61B
144.97
117.68%
14 Buy
0 Hold
0 Sell
Strong Buy
3SBio
HK$22.96
HK$58.27B
1.88
94.91%
6 Buy
1 Hold
0 Sell
Strong Buy
Akeso, Inc.
HK$138.20
HK$127.30B
-84.52
86.38%
7 Buy
1 Hold
0 Sell
Strong Buy
RemeGen Co. Ltd. Class H
HK$106.00
HK$76.84B
51.47
254.52%
6 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$24.94
HK$39.86B
-22.62
83.11%
1 Buy
1 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$83.35
HK$45.30B
34.57
220.58%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IVBXF
Innovent Biologics
11.15
6.02
117.68%
HK:1530
3SBio
22.96
10.20
79.98%
HK:9926
Akeso, Inc.
138.20
51.25
58.94%
HK:9995
RemeGen Co. Ltd. Class H
106.00
75.80
250.99%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
24.94
9.76
64.30%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
83.35
53.00
174.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts